These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18691383)

  • 1. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
    Rambold AS; Miesbauer M; Olschewski D; Seidel R; Riemer C; Smale L; Brumm L; Levy M; Gazit E; Oesterhelt D; Baier M; Becker CF; Engelhard M; Winklhofer KF; Tatzelt J
    J Neurochem; 2008 Oct; 107(1):218-29. PubMed ID: 18691383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
    Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
    Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
    Sunyach C; Checler F
    J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress.
    Katiyar SK; Mukhtar H
    J Leukoc Biol; 2001 May; 69(5):719-26. PubMed ID: 11358979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical chaperones interfere with the formation of scrapie prion protein.
    Tatzelt J; Prusiner SB; Welch WJ
    EMBO J; 1996 Dec; 15(23):6363-73. PubMed ID: 8978663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (-)-epigallocatechin gallate.
    Dorchies OM; Wagner S; Buetler TM; Ruegg UT
    Biofactors; 2009; 35(3):279-94. PubMed ID: 19322813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
    Weinreb O; Amit T; Youdim MB
    Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I; Cardinale A; Mattei S; Biocca S
    J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of glypican-1 autoprocessing in scrapie infection.
    Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
    Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of green tea polyphenols in the inhibition of collagenolytic activity by collagenase.
    Madhan B; Krishnamoorthy G; Rao JR; Nair BU
    Int J Biol Macromol; 2007 Jun; 41(1):16-22. PubMed ID: 17207851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.